* Most popular articles from last 24 hours
-
Sunday, November 15th
Big Pharma Willing to Pay for Biotech Innovation
-
Sanofi-Aventis to Establish Venture Capital Fund, Looking for 'Right Brain Activity'
-
Thursday, November 12th
Why Has Cel-Sci Quietly Amended Some Previously Filed Paperwork?
-
Sunday, November 8th
Week in Review: Major Investments in China Biotech Companies
-
Friday, November 13th
3SBio Inc. Q3 2009 Earnings Call Transcript
-
Thursday, November 12th
American Oriental Bioengineering: Questionable Acquisitions
-
Wednesday, November 11th
Chelsea Therapeutics: There Are Safer Rebound Plays
-
Monday, November 9th
Three Core Biotech Holdings: Isis, Ligand and Vical
-
Sequenom, Inc. Q3 2009 Earnings Call Transcript
-
Monday, November 2nd
3 Holiday Stocking Stuffers for Big Gains in 2010
-
Tuesday, November 3rd
Four Biotech Stocks to Play the Sector Pullback
-
Thursday, November 12th
Cytokinetics' Market Potential
-
Tuesday, November 10th
NexMed Inc. Q3 2009 Earnings Call Transcript
-
Monday, September 7th
Novavax's VLP Technology Is a Game Changer
-
Monday, November 9th
Two Stocks with Market Caps Over $250 Million that Sell for Under $10
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
-
Tuesday, November 10th
Arena Pharmaceuticals Inc. Q3 2009 Earnings Call Transcript